Henderson Jeffrey William
Halozyme Therapeutics, Inc. · Director
Henderson Jeffrey William is listed in filings as Director at Halozyme Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 7, 2026, including sale activity and purchase activity. Recent filings connect the profile to Halozyme Therapeutics, Inc. (HALO), QUALCOMM Inc (QCOM), and Becton Dickinson and Co (BDX). The current snapshot covers public activity from Jan 30, 2025 to May 7, 2026. Reported amounts are shown as $397.9K to $345.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $259k4.3k shares | SellApr 28, 2025 | $60.34 | $77.54 | |
| $12k200 shares | SellApr 28, 2025 | $61.00 | $77.54 |